Immunotherapy Linked to Outcomes in Patients With Cancer and COVID-19

Systemic anticancer therapy, especially immunotherapy (IO), was tied to severe clinical outcomes in patients with cancer and COVID-19. In a study of 12,046 patients, those with baseline immunosuppression treated with systemic therapy, particularly IO, had worse COVID-19 severity and cytokine storm.

Read this Next
About UsOur ProductsCustom SolutionsHow it’s SoldOur ResultsDeliveryContact UsBlogPrivacy PolicyFAQ